Last updated on July 2020

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)


Brief description of study

This study designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative colitis (UC).

Clinical Study Identifier: NCT03519945

Find a site near you

Start Over

Clinical Center Zemun

Zemun, Serbia
3.22miles
  Connect »

Clinical Center of Serbia

Belgrade, Serbia
3.74miles
  Connect »

Clinical Center Zvezdara

Belgrade, Serbia
3.74miles
  Connect »

Military Medical Academy

Belgrade, Serbia
3.74miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.